Evaluating the Impact of New Data From Aromatase Inhibitor Trials on Clinical Practice in Early Breast Cancer: A Canadian Thought Leader Perspective From Drs. Karen Gelmon and Kathleen Pritchard

Canadian breast cancer experts Drs. Karen Gelmon and Kathleen Pritchard discuss clinical implications of evolving data from trials of aromatase inhibitors for women with early breast cancer.

Continue to Evaluating the Impact of New Data From Aromatase Inhibitor Trials on Clinical Practice in Early Breast Cancer: A Canadian Thought Leader Perspective From Drs. Karen Gelmon and Kathleen Pritchard on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz